doi: 10.3389/fphar.2025.1737199 Received 01 November 2025 Revised 21 December 2025 Accepted 29 December 2025 Published 15 January 2026 Volume 16 - 2025 Edited by Dawei Chen, University of Kiel, Germany Reviewed by Eveljn Scarian, University of Pavia, Italy Hong Cheng, Yangzhou University, China Updates Copyright 2026 Knudsen, Tadje, Coggins and Venketaraman
Everyone is always very nice and easy to talk to
These drugs are already available through prescriptions from qualified healthcare providers
The combination of multiple medications affecting gastrointestinal motility should be carefully evaluated, and patients should be monitored for both efficacy and tolerability
With all this in mind, if you are considering taking a GLP-1 medication, talk to your healthcare provider about being prescribed one that's FDA-approved instead of falling for the clever marketing of GLP-1 patches